Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
15 October 2015
Header
Header image
News

News

EU New Trade and Investment Strategy Will Boost Innovation and Patient Access
15 October 2015

EFPIA welcomes the European Commission’s new trade and investment strategy for the European Union as a comprehensive means of addressing existing barriers to trade in [...] Read more

From our blog

From our blog

Why the Pharma Pricing Argument Is Not Black and White
15 October 2015 by Richard Bergström

Pricing is a highly emotive and pressing issue in the pharmaceutical sector. Those who choose to ignore it, or sweep it under the table are sitting on a time bomb that could jeopardise the future sustainability of our health systems and the lives of patients.

Read more

From our blog

Learning the Lessons of Aggregate Disclosure: the UK Perspective (Guest Blog)
15 October 2015 by Karen Borrer (ABPI)

In 2013, the UK pharmaceutical industry first took the step of disclosing the total sum of the payments it had made to healthcare professionals (HCPs) during 2012. Never before done, this was considered, by industry, as a bold move heralding a new era of openness about the existence of these important industry/HCP relationships, which bring life-enhancing and life-saving medicines to patients.

Read more

From our blog

The EFPIA Disclosure Code: What Needs to Be Disclosed?
15 October 2015 by Julie Bonhomme

Across Europe, by the end of June 2016, EFPIA member companies will disclose payments made to health professionals, such as sponsorship to attend meetings, speaker fees, consultancy and advisory boards. How this data will be disclosed will vary according to country; disclosures could be made on company websites or, where available, on a central platform for disclosure. In each case the type of activities subject to the provisions of the EFPIA disclosure code is the same.

Read more

From our blog

How Trade Policy Can Boost Public and Global Health
15 October 2015 by Jana Nackberg

That an effective and open trading system is beneficial for industry, thereby fueling growth and boosting employment is a “no-brainer”. What many people might not recognise, though, is how and to what extent global trade has a significant positive impact on public health.

Read more

Events calendar

Events Calendar

EFPIA Health Collaboration Summit 28-29 October 2015
From 28/10/2015 to 29/10/2015 (Brussels)

The event will bring together senior figures from patient organisations, healthcare systems and industry to discuss outcomes driven, sustainable healthcare in Europe and the role of transparency in developing effective working relationships, capacity building and governance.

In order to share best practice on multi-stakeholder collaborations that benefit patients and healthcare systems, EFPIA and the Patient Think Tank are establishing the Health Collaboration Award.

The Award is open to multi-stakeholder collaborative projects on local, national and EU level that benefit patients. Entrants must include patient organisations and industry partners.

 

 

 

 

 

Please note that the event is full and registration is now closed. Please note that submissions for the Awards closed on 5 October. 

For more information, click here or contact zsofia.bakonyi@efpia.eu.

Read more

Events Calendar

Emerging Medicinal Products – from laboratory to patient use
On 14/12/2015 (De Vere Centre, 1 Westferry Circus, Canary Wharf, London)

The fourth annual regulatory policy summit has been organised by EBE and the European Medicines Agency (EMA).

 

 

 

Read more

Events Calendar

Better Science, Better Health: New Healthcare Models
From 27/10/2015 to 28/10/2015 (Washington DC)

There are currently multiple global initiatives investigating ways to improve and accelerate the way we bring much-needed new medicines to patients. How do we collaborate internationally to create better patient outcomes in the emerging world of precision medicine?

Read more

Events Calendar

Implement, Integrate & Optimise Your Sustainable Serialisation Strategy
From 02/11/2015 to 04/11/2015 (Geneva)

Join the Pharma Serialisation & Traceability 2015 Summit in Geneva! With 22+ presentations from big pharma, CMOs, generics and SMEs, and with the chance to meet directly with regulatory bodies and associations, this event simply cannot be missed.

Read more

Documents

From our blog

Eco-Pharmaco-Stewardship (EPS) - A holistic environmental risk management program
09 October 2015 (Publications)

Read more

What we are reading

What we are reading

UK HCPs back transparency over their pharma payments
15 October 2015 (PM Live)

A poll of healthcare professionals (HCPs) in the UK has found that a majority believe payments made by pharma companies should be made public.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail